Contracts › 75F40125F19006
75F40125F19006: Development and Dissemination of Education Materials on Rare Disease Drug Development
Awarded to Booz Allen Hamilton Inc by Food and Drug Administration (FDA).
$1.5Mobligated
$2.2Mpotential value
14 August 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75F40125F19006 |
|---|---|
| Vehicle | 75F40124A00001 |
| Awardee | Booz Allen Hamilton Inc |
| Awarding agency | Food and Drug Administration (FDA) |
| Awarding office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541611 Administrative Management and General Management Consulting Services |
| PSC | R499 Support- Professional: Other |
| Place of performance | MD |
| Period of performance | 12 August 2025 to 14 August 2027 |
| Potential end | 14 August 2028 |
| Estimated recompete solicitation | ~Q1 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541611 contracts · All expiring contracts · USASpending record